Contact us

  • Who we are
    • Our business model
    • Our leadership
  • What we do
    • Data foundations
    • Target identification
    • Drug programmes
      • Atopic dermatitis
      • Ulcerative colitis
    • Publications
  • Partnering
    • AstraZeneca
  • Sustainability
    • COVID-19
    • Data Diversity Initiative
    • AI principles
  • Investors
    • Announcements
      • Announcement alerts
    • Reports and presentations
    • General meetings
    • Governance
    • Business combination
    • Financial calendar
    • Investor resources
    • Analyst coverage
  • News and media
    • Press releases and in the media
    • Blog and videos
    • Events
    • Newsletter
    • Press kit
  • Careers
    • Culture blog
    • Join our team
    • Internships
Contact us
    • Our business model

      Who we are

      We use AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

      Who we are
    • Our leadership

      Who we are

      We use AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

      Who we are
    Who we are

    Who we are

    We use AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

    Who we are
    • Data foundations

      What we do

      From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

      What we do
    • Target identification

      What we do

      From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

      What we do
      • Atopic dermatitis

        What we do

        From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

        What we do
      • Ulcerative colitis

        What we do

        From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

        What we do
      Drug programmes

      What we do

      From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

      What we do
    • Publications

      What we do

      From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

      What we do
    What we do

    What we do

    From target identification through to clinical development, our AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success.

    What we do
    • AstraZeneca

      Partnering

      We partner with leading pharmaceutical and biotech companies to tackle therapeutic challenges from new angles and develop novel drugs for complex multifactorial diseases.

      Partnering
    Partnering

    Partnering

    We partner with leading pharmaceutical and biotech companies to tackle therapeutic challenges from new angles and develop novel drugs for complex multifactorial diseases.

    Partnering
    • COVID-19

      Sustainability

      BenevolentAI is committed to weaving environmental, social and governance (ESG) stewardship into the fabric of our mission.

      Sustainability
    • Data Diversity Initiative

      Sustainability

      BenevolentAI is committed to weaving environmental, social and governance (ESG) stewardship into the fabric of our mission.

      Sustainability
    • AI principles

      Sustainability

      BenevolentAI is committed to weaving environmental, social and governance (ESG) stewardship into the fabric of our mission.

      Sustainability
    Sustainability

    Sustainability

    BenevolentAI is committed to weaving environmental, social and governance (ESG) stewardship into the fabric of our mission.

    Sustainability
      • Announcement alerts

        Investors

        Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

        Investors
      Announcements

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Reports and presentations

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • General meetings

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Governance

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Business combination

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Financial calendar

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Investor resources

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    • Analyst coverage

      Investors

      Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

      Investors
    Investors

    Investors

    Our investor relations page contains information about BenevolentAI's business for potential investors and analysts: investor presentations, annual reports, governance and events.

    Investors
    • Press releases and in the media

      News and media

      Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

      News and media
    • Blog and videos

      News and media

      Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

      News and media
    • Events

      News and media

      Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

      News and media
    • Newsletter

      News and media

      Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

      News and media
    • Press kit

      News and media

      Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

      News and media
    News and media

    News and media

    Get the latest news and updates from BenevolentAI on our AI-driven drug and research programmes, collaborations, investments and events.

    News and media
    • Culture blog

      Careers

      Join us to work on a mission that matters: uniting AI and cutting-edge science to discover and develop new medicines for complex diseases.

      Careers
    • Join our team

      Careers

      Join us to work on a mission that matters: uniting AI and cutting-edge science to discover and develop new medicines for complex diseases.

      Careers
    • Internships

      Careers

      Join us to work on a mission that matters: uniting AI and cutting-edge science to discover and develop new medicines for complex diseases.

      Careers
    Careers

    Careers

    Join us to work on a mission that matters: uniting AI and cutting-edge science to discover and develop new medicines for complex diseases.

    Careers
7. Culture Blog.jpg

Culture blog

  • Home
  • Careers
  • Culture blog
Tracys_BenevolentStory__the_many_hats_of_an_operations_manager_at_BenevolentAI.jpg
Tracy’s #BenevolentStory: the many hats of an operations manager at BenevolentAI
Read more
Michaels_BenevolentStory__finding_motivation_in_doing_drug_discovery_differently.jpg
Michael’s #BenevolentStory: finding motivation in ‘doing drug discovery differently’
Read more
Annas_BenevolentStory__empowering_women_to_create_a_more_equal_workplace.jpg
Anna’s #BenevolentStory: Empowering Women To Create A More Equal Workplace
Read more
Ollys_BenevolentStory__reflections_on_six_years_of_building_software_for_scientists.jpg
Olly’s #BenevolentStory: reflections on six years of building software for scientists
Read more
Overcoming_stigma_and_challenges_facing_women_the_tech_industry.jpg
Overcoming stigma and challenges facing women the tech industry
Read more
Internship_Programme_FAQ.jpg
Internship Programme FAQ
Read more
Meet_our_2021_intern_cohort.jpg
Meet our 2021 intern cohort
Read more
Transforming_drug_discovery_with_AI__how_were_building_and_nurturing_the_best_talent_for_the_job.jpg
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
Read more
Tech_Nation_Visa__the_gateway_to_world-leading_UK_tech_jobs.jpg
Tech Nation Visa: the gateway to world-leading UK tech jobs
Read more
What_to_expect_from_your_internship_at_BenevolentAI.jpg
What to expect from your internship at BenevolentAI
Read more
Meet_our_2021_intern_cohort.jpg
Meet the BenevolentAI 2020 Intern Cohort
Read more
Careers_with_Impact__5_learnings_from_machine_learning_applied_drug_discovery.jpg
Careers with Impact: 5 learnings from machine learning applied drug discovery
Read more
Building_the_next_generation_of_leaders_with_Circl.jpg
Building the next generation of leaders with Circl
Read more
Yoga_and_mental_health__a_conversation_between_two_professional_scientists_and_professional_yogis.jpg
Yoga and mental health: a conversation between two professional scientists and professional yogis
Read more
Kindness_matters__mental_health_and_wellbeing_through_COVID-19_and_beyond.jpg
Kindness matters: mental health and wellbeing through COVID-19 and beyond
Read more
One_team_one_mission__nurturing_a_culture_of_innovation_and_collaboration.jpg
One team, one mission: nurturing a culture of innovation and collaboration
Read more
Who we are
Our leadership
Blog and videos

Contact us

Registered address
9 rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

  • Drug programmes
  • Partnering
  • Investors
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie declaration
  • Accessibility
  • Sitemap

Company registration: R.C.S. Luxembourg: B255412

©BenevolentAI 2023